Dr. Ignacio Bernabeu Morón, endocrino

Dr. Ignacio Bernabeu Morón, endocrino

citations

Pasa consulta en Santiago

  • Licenciado en Medicina y Cirugía por la Universidad Complutense de Madrid (1984).
  • Especialista en Endocrinología y Nutrición, Clínica Puerta de Hierro (Universidad Autónoma de Madrid) 1989.
  • Doctor en Medicina y Cirugía, Universidad de Santiago de Compostela (2010).
  • Profesor Asociado de Medicina de la USC.
  • Ejercicio profesional como Endocrinólogo desde 1990.
  • Actividad científica en http://scholar.google.es/citations?user=YuyH1pcAAAAJ.

 

ACTIVIDAD CIENTIFICA: Citado por Año
High prevalence of AIP gene mutations following focused screening in young patients with sporadic pituitary macroadenomas
MA Tichomirowa, A Barlier, AF Daly, ML Jaffrain-Rea, C Ronchi, …
European Journal of Endocrinology 165 (4), 509-515
45 2011
Coadministration of lanreotide Autogel and pegvisomant normalizes IGF1 levels and is well tolerated in patients with acromegaly partially controlled by somatostatin analogs alone
AJ van der Lely, I Bernabeu, J Cap, P Caron, A Colao, J Marek, …
European Journal of Endocrinology 164 (3), 325-333
22 2011
Genetic diagnosis of X-linked dominant Hypophosphatemic Rickets in a cohort study: tubular reabsorption of phosphate and 1, 25 (OH) 2D serum levels are associated with PHEX mutation type
M Morey, L Castro-Feijóo, J Barreiro, P Cabanas, M Pombo, M Gil, …
BMC medical genetics 12 (1), 116
19 2011
Pituitary stalk dysgenesis-induced hypopituitarism in adult patients: prevalence, evolution of hormone dysfunction and genetic analysis
E Fernandez-Rodriguez, C Quinteiro, J Barreiro, M Marazuela, I Pereiro, …
Neuroendocrinology 93 (3), 181-188
17 2011
Pegvisomant-induced liver injury is related to the UGT1A1* 28 polymorphism of Gilbert’s syndrome
I Bernabeu, M Marazuela, T Lucas, L Loidi, C Alvarez-Escolá, …
The Journal of Clinical Endocrinology & Metabolism 95 (5), 2147-2154
17 2010
Somatotroph tumor progression during pegvisomant therapy: a clinical and molecular study
M Marazuela, AE Paniagua, MD Gahete, T Lucas, C Alvarez-Escolá, …
The Journal of Clinical Endocrinology & Metabolism 96 (2), E251-E259
15 2010
Long-term treatment of acromegalic patients resistant to somatostatin analogues with the GH receptor antagonist pegvisomant: its efficacy in relation to gender and previous radiotherapy
M Marazuela, T Lucas, M Puig-Domingo, NG de la Torre, …
European Journal of Endocrinology 160 (4), 535-542
15 2009
The exon 3-deleted growth hormone receptor is associated with better response to pegvisomant therapy in acromegaly
I Bernabeu, C Alvarez-Escolá, C Quinteiro, T Lucas, M Puig-Domingo, …
The Journal of Clinical Endocrinology & Metabolism 95 (1), 222-229
13 2010
Anterior pituitary function in Cushing’s syndrome: study of 36 patients.
C Cuerda, J Estrada, M Marazuela, A Vicente, B Astigarraga, I Bernabeu, …
Endocrinologia japonica 38 (5), 559-563
12 1991
Pegvisomant and cabergoline combination therapy in acromegaly
I Bernabeu, AE Paniagua, T Lucas, I Pavón, FF Casanueva, M Marazuela
Pituitary 16 (1), 101-108
11 2013
Changes in acromegaly treatment over four decades in Spain: analysis of the Spanish Acromegaly Registry (REA)
G Sesmilo, S Gaztambide, E Venegas, A Picó, C Del Pozo, C Blanco, …
Pituitary 16 (1), 115-121
10 2013
Alvarez-Escolá C, Quinteiro C, Lucas T, Puig-Domingo M, Luque-Ramírez M, de Miguel-Novoa P, Fernandez-Rodriguez E, Halperin I, Loidi L, Casanueva FF, Marazuela M: The exon 3-deleted growth hormone receptor is associated with better response to pegvisomant therapy in acromegaly
I Bernabeu
J Clin Endocrinol Metabol 95 (1), 222-229
8 2010
Álvarez-Escolá C, Quinteiro C, Lucas T, Puig-Domingo M, Luque-Ramírez M, et al. The exon 3-deleted growth hormone receptor is associated with better response to pegvisomant therapy in acromegaly
I Bernabeu
J Clin Endocrinol Metab 95 (1), 222-9
6 2010
Epidemiology, mortality rate and survival in a homogeneous population of hypopituitary patients
E Fernandez‐Rodriguez, M Lopez‐Raton, P Andujar, IM Martinez‐Silva, …
Clinical endocrinology 78 (2), 278-284
5 2013
Subclinical hypopituitarism
E Fernandez-Rodriguez, I Bernabeu, P Andujar-Plata, FF Casanueva
Best Practice & Research Clinical Endocrinology & Metabolism 26 (4), 461-469
5 2012
Pegvisomant-induced cholestatic hepatitis with jaundice in a patient with Gilbert’s syndrome
I Bernabeu, J Cameselle-Teijeiro, FF Casanueva, M Marazuela
European Journal of Endocrinology 160 (5), 869-872
5 2009
High Incidence of AIP mutations in sporadic pituitary adenomas in young patients with macroadenomas
MA Tichomirova, A Daly, A Barlier, ML Jaffrain-Réa, S Zacharieva, …
The Endocrine Society’s 91st Annual Meeting: 10-13 juin 2009, Washington
5 2009
Germline mutations of AIP gene in somatotropinomas resistant to somatostatin analogues
J Oriola, T Lucas, I Halperin, M Mora, MJ Perales, GD Soto, I Salinas, …
European Journal of Endocrinology 168 (1), 9-13
4 2013
Hypopituitarism following traumatic brain injury: determining factors for diagnosis
E Fernandez-Rodriguez, I Bernabeu, AI Castro, F Kelestimur, …
Frontiers in endocrinology 2
4 2011
Hormone Use and Abuse by Athletes
Springer
4 2010
Cabergoline treatment in acromegaly: pros
M Marazuela, A Ramos-Leví, M Sampedro-Núñez, I Bernabeu
Endocrine, 1-5
3 2014
Metabolic syndrome associated with hyperprolactinemia: A new indication for dopamine agonist treatment?
I Bernabeu, FF Casanueva
Endocrine 44 (2), 273-274
3 2013
El año 2011 en Neuroendocrinología
M Puig Domingo, J Castaño, E Resmini, E Venegas, J García Arnés, …
Endocrinología y Nutrición
2 2012
Thyroid-type solid cell nests in struma ovarii
J Cameselle-Teijeiro, N Caramés, A Romero-Rojas, R Reyes-Santías, …
International journal of surgical pathology 19 (5), 627-631
2 2011
Tratamiento farmacológico de los tumores neuroendocrinos gastroenteropancreáticos: análogos de somatostatina
M Marazuela Azpíroz, E Ignacio Bernabeu Morón
Endocrinología y Nutrición 54, 44-50
2 2007
Characteristics of the Spanish version of the quality of life questionnaire (QLSM-H) in adult subjects with growth hormone deficiency treated with somatotropin: pilot study
IJ Bernabeu, S Gaztambide, E Menendez, SM Webb, A Garcia-Patterson, …
Endocrinología y nutrición 49 (4), 105-112
2 2002
Lanreotide autogel‐induced tumour shrinkage in thyrotropin‐secreting pituitary macroadenomas
AE Paniagua, I Bernabeu, S Leskela, M Marazuela
Clinical endocrinology 74 (3), 406-408
1 2011
[Thyrotropin-producing adenoma of the hypophysis]
R Araujo, J Estrada, S Díez, I Bernabeu, CP Salto
Medicina clinica 93 (15), 578-580
1 1989
[Description of Wolfram syndrome (DIDMOAD) on the basis of a new case]
MI Bernabeau, GR Cámara, AR Araujo, AS Díez, GJ Estrada, MT Lucas, …
Revista clinica espanola 184 (8), 418-420
1 1989
Update on prognostic factors in acromegaly: Is a risk score possible?
E Fernandez-Rodriguez, FF Casanueva, I Bernabeu
Pituitary, 1-10
2014
Influence of the exon 3 deletion of GH receptor and IGF-I level at diagnosis on the efficacy and safety of treatment with somatotropin in adults with GH deficiency
P Andujar-Plata, E Fernandez-Rodriguez, C Quinteiro, FF Casanueva, …
Pituitary, 1-7
2014
Escape and lipodystrophy in acromegaly during pegvisomant therapy, a retrospective multicentre Spanish study
G Sesmilo, E Resmini, I Bernabeu, J Aller, A Soto, M Mora, A Picó, …
Clinical endocrinology
2014
Consensus document of the Neuroendocrinology area of the Spanish Society of Endocrinology and Nutrition on management of hypopituitarism during transition
C Álvarez-Escolá, E Fernández-Rodríguez, JM Recio-Córdova, …
Endocrinología y Nutrición (English Edition) 61 (2), 68. e1-68. e11
2014
Documento de consenso del área de conocimiento de Neuroendocrinología de la Sociedad Española de Endocrinología y Nutrición para el abordaje del hipopituitarismo durante la transición
C Álvarez-Escolá, E Fernández-Rodríguez, JM Recio-Córdova, …
Endocrinología y Nutrición 61 (2), 68. e1-68. e11
2014
Adrenal carcinoma: a retrospective analysis of our series.
P Andujar, JM Cameselle-Teijeiro, F Barón-Duarte, I Bernabeu, …
Endocrinologia y nutricion: organo de la Sociedad Espanola de Endocrinologia …
2013
Prevalence of escape and lipodystrophy in patients treated with Pegvisomant. A multicenter study
G Sesmilo, E Resmini, I Bernabeu, J Aller, A Soto, M Marazuela, M Mora, …
BioScientifica
2013
Spanish molecular registry of pituitary adenomas: a multicenter, translational approach aimed at improving patient management
A Leal-Cerro, RM Luque, L Sanchez-Tejada, A Ibanez-Costa, M Jorda, …
BioScientifica
2013
Evaluation of the efficacy of midnight salivary cortisol plus dexamethasone suppression test as screening for the diagnosis of hypercortisolism within an at-risk population
A Leal-Cerro, A Madrazo-Atutxa, J Garcia-Arnes, C Lamas-Oliveira, …
BioScientifica
2013
Efficacy and safety of lanreotide in combination with pegvisomant in clinical practice in patients with active acromegaly with monotherapy failure
E Venegas, T Lucas, M Marazuela, G Cuatrecasas, MA Galvez, E Romero, …
BioScientifica
2013
Efficacy and safety of lanreotide in combination with cabergoline in clinical practice in patients with active acromegaly with monotherapy failure
R Vilchez, I Bernabeu, C Blanco, F Cordido, M Paja, R Casany, C Fajardo, …
BioScientifica
2013
Documento de consenso del área de conocimiento de Neuroendocrinología de la Sociedad Espanola de Endocrinología y Nutrición para el abordaje del hipopituitarismo durante la transición
JM Recio-Córdova, I Bernabéu-Morón
2013
Protocolo diagnóstico y terapéutico de las hipofisitis
E Fernández-Rodríguez, I Bernabeu, FF Casanueva
Medicine-Programa de Formación Médica Continuada acreditado 11 (13), 800-803
2012
Diagnóstico y tratamiento del incidentaloma hipofisario
P Andújar, E Fernández-Rodríguez, I Bernabeu, FF Casanueva
Medicine-Programa de Formación Médica Continuada acreditado 11 (13), 792-795
2012
Adenomas hipofisarios no funcionantes
P Andújar, E Fernández-Rodríguez, I Bernabeu, FF Casanueva
Medicine-Programa de Formación Médica Continuada acreditado 11 (13), 757-763
2012
Protocolo de diagnóstico y tratamiento de la hiperprolactinemia
E Fernández-Rodríguez, I Bernabeu, FF Casanueva
Medicine-Programa de Formación Médica Continuada acreditado 11 (13), 796-799
2012
Indicaciones y secuencia de empleo de las pruebas funcionales hipofisarias. Criterios de valoración
P Andújar, E Fernández-Rodríguez, I Bernabeu, FF Casanueva
Medicine-Programa de Formación Médica Continuada acreditado 11 (13), 788-791
2012
Enfermedades de la neurohipófisis
E Fernández-Rodríguez, I Bernabeu, FF Casanueva
Medicine-Programa de Formación Médica Continuada acreditado 11 (13), 782-787
2012
Adenomas hipofisarios funcionantes
E Fernández-Rodríguez, I Bernabeu, FF Casanueva
Medicine-Programa de Formación Médica Continuada acreditado 11 (13), 764-772
2012
Mujer de 32 años con antecedentes de migraña que consulta por galactorrea bilateral y oligomenorrea
E Fernández-Rodríguez, P Andújar, I Bernabéu, FF Casanueva
Medicine-Programa de Formación Médica Continuada acreditado 11 (13), 804. e1 …
2012
Patología del eje hipotálamo-hipofisario. Tumores pineales
P Andújar, E Fernández-Rodríguez, I Bernabeu, FF Casanueva
Medicine-Programa de Formación Médica Continuada acreditado 11 (13), 751-756
2012
Hipopituitarismo. Panhipopituitarismo
E Fernández-Rodríguez, I Bernabeu, FF Casanueva
Medicine-Programa de Formación Médica Continuada acreditado 11 (13), 773-781
2012
Mortality and survival in a large series of adult patients with hypopituitarism followed for 10 years
E Fernandez-Rodriguez, M Lopez-Raton, C Cadarso, F Casanueva, …
BioScientifica
2012
Estudio clínico y molecular de cinco familias con resistencia a la acción de las hormonas tiroideas
J Lado Abeal, R Albero Gamboa, D Araujo Vilar, O Barca Mallo, …
Medicina Clínica 137 (12), 551-554
2011
Prevalence of germline mutations of AIP gene in sporadic aggressive somatotropinomas
M Puig-Domingo, J Oriola, I Halperin, M Mora, G Diaz-Soto, MJ Perales, …
BioScientifica
2011
GH/IGF-I Axis in Exercise
E Gabellieri, I Bernabeu, E Fernandez, M Marazuela, L Chiovato, …
Hormone Use and Abuse by Athletes, 1-7
2011
General concepts of hypothalamus-pituitary anatomy
I Bernabeu, M Marazuela, FF Casanueva
Oxford Textbook of Endocrinology and Diabetes (2 ed.) 2011
2011
Nell’acromegalia la delezione dell’esone 3 del recettore del GH si associa a una migliore risposta alla terapia con pegvisomant
I Bernabeu, C Quinteiro, T Lucas, M Puig-Domingo, M Luque-Ramírez, …
L’Endocrinologo 11 (5), 231-232
2010
Lanreotide-ATG effectiveness on tumoral mass shrinkage of two thyrotropin-secreting pituitary macroadenomas
A Paniagua, I Bernabeu, M Marazuela
BioScientifica
2010
Efficacy and safety of co-administration of lanreotide Autogel 120 mg monthly with pegvisomant weekly in patients with acromegaly partially controlled by somatostatin analogues
AJ van der Lely, I Bernabeu, J Cap, P Caron, A Colao, C Lesage, J Marek, …
BioScientifica
2010
Cholestatic hepatitis with jaundice in a patient with Gilbert’s syndrome: case report
I Bernabeu
Reactions 1257, 20
2009
Actualización del tratamiento con radioyodo: utilidad de la TSH humana recombinante
A Ruibal Morell, V Pubul-Núñez, I Bernabéu Morón
Endocrinología y nutrición: órgano de la Sociedad Española de Endocrinología …
2005
Protocolo diagnóstico de la hipo e hiperfosfatemia
I Bernabéu Morón
Medicine-Programa de Formación Médica Continuada Acreditado 9 (17), 1083-1085
2004
Hipofosfatemia e hiperfosfatemia: concepto, fisiopatología, etiopatogenia, clínica, diagnóstico y tratamiento
I Bernabéu Morón
Medicine 9 (17), 1063-1069
2004
THYROTROPIN PRODUCING PITUITARY-ADENOMA
R ARAUJO, J ESTRADA, S DIEZ, I BERNABEU, C PARAMO, L SALTO
MEDICINA CLINICA 93 (15), 578-580
1989
Epidemiologic Features and Predictors of Mortality in a Cohort of Adult Patients with Hypopituitarism
E Fernandez-Rodriguez, I Bernabeu, FF Casanueva
Signs and Symptoms of Pituitary Disease
E Fernandez‐Rodriguez, I Bernabeu, FF Casanueva, EN Kassi, …
Pituitary Disorders: Diagnosis and Management, 13-20

Volver al cuadro médico

Uso de cookies

Este sitio web utiliza cookies para que usted tenga la mejor experiencia de usuario. Si continúa navegando está dando su consentimiento para la aceptación de las mencionadas cookies y la aceptación de nuestra política de cookies, pinche el enlace para mayor información.

ACEPTAR
Aviso de cookies